Online Tool Aids Decision Making About Breast Cancer Treatment

Share this content:
Online Tool Aids Decision Making About Breast Cancer Treatment
Online Tool Aids Decision Making About Breast Cancer Treatment

WEDNESDAY, Feb. 21, 2018 (HealthDay News) -- The interactive iCanDecide breast cancer treatment decision tool can improve high-quality decision making about breast cancer surgical treatment, according to a study published online Jan. 24 in the Journal of Clinical Oncology.

Sarah T. Hawley, Ph.D., from the University of Michigan in Ann Arbor, and colleagues randomized 537 patients with newly diagnosed, early-stage breast cancer to the iCanDecide interactive and tailored website (intervention) or the iCanDecide static website (control).

The researchers found that patients in the intervention arm had higher odds of making a high-quality decision versus those in the control arm (odds ratio, 2.00; P = 0.0004). This difference was driven primarily by the rates of high knowledge in the groups. In the intervention arm, more patients had high decision preparation (P = 0.027), but there were no significant differences in the other decision appraisal outcomes. The effect of the intervention was similar for women at enrollment who were leaning strongly toward a treatment option versus with those who were not.

"To be effective, future patient-facing decision tools should be integrated into the clinical workflow to improve decision making," the authors write.

Several authors disclosed financial ties to the diagnostics and pharmaceutical industries.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

More U.S. Teens Are Vaping, but Use of ...

About 37 percent of 12th graders said they had vaped within the previous 12 months

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With ...

Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Treatment costs less than extended-release naltrexone without negative impact on outcomes

is free, fast, and customized just for you!




Already a member?

Sign In Now »